Measurement of serum calcium concentration after administration of gadoversetamide in dogs.
Wible
James H
JH
Tyco Healthcare/Mallinckrodt Imaging, 675 McDonnell Blvd, PO Box 5840, St Louis, MO 63134, USA. james.wible@tycohealthcare.com
Hynes
Michael R
MR
D000704:Analysis of Variance; D000818:Animals; D002118:Calcium / Q000097:blood*; D002614:Chelating Agents; D004396:Coloring Agents; D003287:Contrast Media / Q000008:administration & dosage*; D004285:Dogs; D005260:Female; D005682:Gadolinium / Q000008:administration & dosage*; D019786:Gadolinium DTPA / Q000008:administration & dosage; D006571:Heterocyclic Compounds / Q000008:administration & dosage; D007275:Injections, Intravenous; D008297:Male; D013058:Mass Spectrometry; D009942:Organometallic Compounds / Q000008:administration & dosage*; D010635:Phenolphthaleins; D013997:Time Factors
D002614:Chelating Agents; D004396:Coloring Agents; D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; D010635:Phenolphthaleins; C062402:gadoteridol; C064925:gadodiamide; C017845:2-cresolphthalexon; D005682:Gadolinium; D019786:Gadolinium DTPA; C112666:gadoversetamide; D002118:Calcium